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Copyright © 2008 AHC Inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) are Ca2+ channels that localize to intra-
cellular Ca2+ stores such as the endoplasmic reticulum (ER). Recently, IP3Rs were found to
participate in the formation of the cytoskeleton and cellular adhesions. In this study, we
examined the cellular localization of type I, II, and III IP3Rs to assess their role in cellular
adhesion in rat osteoclasts. Rat bone marrow cells were cultured in α-MEM with 10% fetal
bovine serum, M-CSF, RANKL, and 1,25(OH)2D3 for 1 week to promote osteoclast forma-
tion. Type I, II, and III IP3R expression in the osteoclasts was then examined by RT-PCR.
Double-staining was performed using antibodies against type I, II, and III IP3Rs and DiOC6,
an ER marker, or TRITC-phalloidin, an actin filament marker. Expression of all three IP3Rs
was detected in the newly formed osteoclasts; however, the localization of the type I and II
IP3Rs was predominantly close to nuclear, and possibly colocalized with the ER, while the
type III IP3Rs were localized to the ER and podosomes, actin-rich adhesion structures in os-
teoclasts. These findings suggest that type III IP3Rs are associated with osteoclast adhesion.
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I. Introduction
The second messenger inositol 1,4,5-trisphosphate
(IP3) is produced primarily by the metabolism of phospho-
inositol-4,5-bisphosphate by phospholipase C in response to
the stimulation of G protein-coupled receptors or receptor
tyrosine kinases [22]. IP3-mediated Ca2+ signaling controls
important cellular functions such as contraction, secretion,
gene expression, and synaptic plasticity [18]. IP3 causes the
release of Ca2+ into the cytoplasm by binding IP3 receptors
(IP3Rs) on intracellular Ca2+ stores such as the endoplasmic
reticulum (ER) [27]. At least three distinct IP3R subtypes
(types I, II, and III) [7, 31] exist, which are expressed in a
tissue- and development-specific manner and form hetero-
tetrameric channels [22]. The expression patterns of the
subtypes may be responsible for the production of a cell
type-specific Ca2+ signal. Recent studies of the individual
IP3R subtypes in lipid bilayers have suggested functional
differences [18], and IP3R type II has been reported in the
plasma membrane and karyotheca in addition to the ER,
where they are closely associated with actin filaments. The
IP3Rs that are localized to the plasma membrane may func-
tion in the formation of the cytoskeleton and cellular adhe-
sions [27].
Skeletal modeling during growth and bone remodeling
in the skeleton are dependent on bone resorption, which is
mediated by osteoclasts. Osteoclasts are large multinucle-
ated, highly motile and invasive cells of hematopoietic
origin. Osteoclast-mediated bone resorption is tightly regu-
lated at multiple levels, and excessive osteoclast activity
results in a progressive loss of bone mass and deterioration
of bone architecture, leading to a variety of diseases [11,
15]. The resorptive activity of osteoclasts depends on their
adhesion to the bone surface. When bone resorption is in-
duced, osteoclasts migrate to the site of resorption where
they become highly polarized and form four distinct mem-
brane domains: the ruffled border, sealing zone, functional
secretory domain, and basolateral domain [28]. The pri-Morikawa et al. 8
mary adhesive structures of osteoclasts are dot-like actin-
rich structures known as podosomes [15, 24], and the
dynamic changes in the cytoskeletal organization and distri-
bution pattern of these podosomes can occur within minutes.
The distribution of actin in cells helps determine cell inte-
grity, shape, adhesion, and motility [1]. Podosomes are
present not only in osteoclasts, but also in other monocyte-
derived cells, such as macrophages and dendritic cells, as
well as in smooth muscle cells, endothelial cells, trans-
formed fibroblasts, and certain epithelial cells [15].
The localization of each IP3R subtype (I, II, and III) in
osteoclasts is unknown. Therefore, we examined the cellular
localization of each subtype and its colocalization with
cytoskeletal proteins to elucidate their involvement in
cellular adhesion.
II. Materials and Methods
Reagents and antibodies
Human receptor activator of nuclear factor κB ligand
(RANKL) and human macrophage colony-stimulating fac-
tor (M-CSF) were obtained from Wako (Tokyo, Japan),
while 1α,25-dihydroxyvitamin D3 was purchased from
Funakoshi (Tokyo, Japan). Alexa Fluor 488 goat anti-rabbit
IgG antibody, Alexa Fluor 568 goat anti-rabbit IgG anti-
body, TRITC-phalloidin, and 3,3'-dihexyloxacarbocyanine
iodide (DiOC6) were purchased from Invitrogen-Molecular
Probes (Tokyo, Japan). Anti-IP3R type I, II, and III rabbit
polyclonal antibodies were provided by one of the authors of
this paper, Dr. Akihiro Tanimura of the Health Sciences
University of Hokkaido, Hokkaido, Japan [29].
Osteoclast culture
The experimental protocol in rats was reviewed and ap-
proved by the Animal Care Committee at Kyushu Dental
College, Fukuoka, Japan. Twenty-four male Sprague-
Dawley rats weighing 200–250 g were used. Rat bone
marrow cells were isolated by a modified version of a pre-
viously published method [9, 13, 21]. Briefly, tibiae from
7-week-old Sprague-Dawley rats were dissected free of
adhering tissue. Next, the ends of the bones were removed,
and the marrow cavity was flushed with α-minimal essen-
tial medium (α-MEM; Gibco, Grand Island, NY) containing
heat-inactivated fetal bovine serum (FBS; Wako), genta-
micin (Gibco), amphotericin B (Gibco), and penicillin G
(Wako) by slowly injecting the medium into one end of
the bone using a sterile 22-gauge needle. The marrow cells
were collected in tubes, centrifuged at 1,500×g for 5 min,
aspirated, and mixed with 0.83% NH4Cl and 10 mM Tris.
They were centrifuged again at 1,500×g for 5 min and
then aspirated and covered with fresh medium. Finally,
the cells were plated in 35-mm culture dishes on cover
glasses (5×105 cells/dish) and in 96-well plates on a dentin
slice (7×104 cells/well), and cultured for 7 days at 37°C
under 5% CO2 in α-MEM containing 10% FBS, 1% genta-
micin/amphotericin B/penicillin G, 10−7 M 1α,25-dihydroxy-
vitamin D3, 25 ng/ml M-CSF, and 20 ng/ml RANKL. Fresh
medium was added every 3 days. The formation of osteo-
clast-like multinucleated cells was confirmed by an Olym-
pus IMT-2 inverted phase contrast microscope (Olympus
Optical Co., Ltd., Tokyo, Japan).
Reverse transcription-polymerase chain reaction (RT-PCR)
Bone marrow cells were cultured for 1 week, then incu-
bated with 0.01% Pronase/0.02% EDTA for 10 min at 37°C
to obtain an osteoclast-rich population [6]. mRNA was then
extracted using a Total RNA Extraction Miniprep System
(Viogene, Sunnyvale, CA) according to the manufacturer’s
protocol. To reduce DNA contamination, the samples were
treated with RNase-free DNase I (Takara Bio, Shiga, Japan)
for 3 hr at 37°C. cDNA was synthesized from 2 µg of total
RNA in 30 µL of reaction buffer containing 500 µM dNTPs,
20 U of ribonuclease inhibitor (Promega, Madison, WI), and
200 U of Superscript II reverse transcriptase (Invitrogen Life
Technologies, Carlsbad, CA). Each reaction was carried out
as follows: 70°C for 7 min, 45°C for 60 min, 70°C for 10
min, and 4°C. The primers used to amplify IP3R-I were 5'-
TGG CAG AGA TGA TCA GGG AAA-3' and 5'-GCT CGT
TGT GTT CCC CTT CAG-3' (GenBank J05510; 8314–
8334 and 8389–8409) [2]. For IP3R-II, they were 5'-GGC
ACA GCC TCT CCA TGT GGC AGG-3' and 5'-TTC CTG
TCT CGC TGA CCC CAG TGC-3' (GenBank X61677;
8568–8591 and 8742–8765); for IP3R-III, 5'-CAC GGA
GCT GCC ACA TTT ATG GGC-3' and 5'-TCC TCA GTC
CGT GGT TCA TGA CGG-3' (GenBank L06096; 7377–
7400 and 7522–7545) [3]; for cathepsin K, 5'-CCC AGA
CTC CAT CGA CTA TCG-3' and 5'-CTG TAC CCT CTG
CAC TTA GCT GCC-3' (GenBank BC078793; 418–438
and 724–747) [16]. Each cycle consisted of denaturation at
94°C for 1 min, annealing at 60°C for 1 min, and a 1-min ex-
tension at 72°C for 35, or 30 cycles for the IP3Rs, cathepsin
K, respectively, with a final 9-min extension at 72°C. To
confirm the reproducibility of our results, each experiment
was repeated at least three times. Each reaction mixture con-
sisted of cDNA, Taq polymerase buffer, and 1 µL of each of
the sense and antisense primers, for a total volume of 20 µL.
The amplified products were electrophoresed in 2% agarose
gels and visualized with ethidium bromide. The specificity
of each primer was confirmed using a BLAST-assisted
Internet search of nonredundant nucleotide sequence data-
bases (National Library of Medicine, Bethesda, MD).
Immunocytochemistry
The bone marrow cells, thus cultured for 1 week as
described above, were fixed in 4% paraformaldehyde for
10 min and then treated with 0.5% Triton X-100 for 10 min.
After washing with PBS three times, the cells were
blocked with 1% whole goat serum (Nichirei, Tokyo, Japan)
for 30 min, washed three times in PBS, and incubated with
anti-IP3R type I, II, and III rabbit IgG antibodies (1:100)
overnight at 4°C. After another three washes with PBS,
the samples were incubated with Alexa Fluor 568 goat
anti-rabbit IgG antibody (1:40) for 2 hr at 37°C. After wash-
ing, the cells were incubated with 1 µg/mL DiOC6, an ERIP3 Receptors in Osteoclasts 9
marker, for 30 min at room temperature. After incubation
with the primary antibodies, some samples were incubated
with Alexa Fluor 488 goat anti-rabbit IgG antibody (1:40)
for 2 hr at 37°C. After washing, the cells were incubated
with TRITC-labeled phalloidin (1:40) for 1 hr at 37°C. The
samples were examined under a confocal laser scanning
microscope (Radiance 2100, Bio-Rad, Herts, UK) equipped
for fluorescence and Nomarski optics.
III. Results
IP3R subtype expression
IP3R subtype expression in a rat osteoclast-rich popula-
tion was examined using subtype-specific primers. Amplifi-
cation was observed in all three cases, indicating that all
three IP3R subtypes are expressed at the mRNA level in
cultured rat osteoclasts (Fig. 1a). To verify that the RNA
was derived from osteoclasts, expression of cathepsin K, an
osteoclast marker, was confirmed in each population (Fig.
1b, c). The formation of osteoclast-like multinucleated
giant cells was confirmed by a phase contrast microscope
(Fig. 1d).
Colocalization of the IP3R subtypes with the ER
We next investigated the degree of colocalization
between the IP3Rs and the ER in rat osteoclasts cultured on
cover glasses. IP3R type I was predominantly observed close
to the nuclear region near the ER, which was stained by
DiOC6 (Fig. 2a–d). IP3R type II was ER-localized, similar to
IP3R type I (Fig. 2e–h). The localization of IP3R type III was
similar to that of IP3R types I and II; however, additional
immunopositive reactions were observed at the periphery
of the osteoclasts (Fig. 2j). To eliminate the possibility of
cross-talk in double-staining between DiOC6 and each IP3R,
we performed each IP3R immunostaining without DiOC6
staining (Fig. 2m, n, o). In these cases, we obtained the same
results as mentioned above. Control samples treated without
primary antibody showed no signal (Fig. 2p).
Colocalization of IP3R type III with podosomes
To examine the relationship between IP3R type III and
podosomes, we used IP3R type III immunofluorescence
staining with TRITC-phalloidin staining to visualize the ac-
tin filaments in the cells. In terms of the localization of IP3R
type III, dot-like signals were observed at the periphery of
the osteoclasts (Fig. 3a, c, h); the TRITC-phalloidin staining
revealed substantial homology between the distribution of
the type III IP3Rs and the podosomes (Fig. 3a–d, h–k). The
colocalization of the IP3Rs and podosomes were confirmed
by an X/Z reconstruction section (Fig. 3e, f, g). To eliminate
the possibility of cross-talk in double-staining between
TRITC-phalloidin and IP3R type III, we performed IP3R
type III immunostaining without TRITC-phalloidin staining.
Staining for IP3R type III alone revealed dot-like immuno-
positive reactions at the periphery of the osteoclasts (Fig.
3l). Control staining without primary antibody produced no
signal (Fig. 3m).
Double-staining for IP3R type III and actin was also
performed in osteoclasts cultured on a dentin slice. An actin
band representing accumulated podosomes, which was
colocalized with IP3R type III, was observed (Fig. 4).
IV. Discussion
Our results indicate that IP3Rs are distributed predomi-
nantly along the ER; however, type III IP3Rs are also local-
ized at podosomes, the osteoclast attachment structures. This
study is the first paper to show an association between IP3Rs
and the attachment structures in osteoclasts.
In this study, we found that osteoclasts express three
types of IP3Rs (I, II, and III) that are colocalized with the ER
around the nucleus, although type III IP3Rs may also be
found as punctate structures at the periphery. These puncta
correspond to osteoclast attachment regions known as podo-
somes. Several previous studies have suggested that IP3Rs
are present at the plasma membrane. Moreover, type II and
type III IP3Rs, and possibly other as yet undiscovered IP3Rs,
have been suggested to contain sorting signals that are dis-
tinct from those of type III IP3Rs, which may target them to
the plasma membrane [26]. In addition, type III IP3Rs have
been detected around the nucleus and at the plasma mem-
brane in vascular smooth muscle cells [30]. Although the lo-
calization of IP3Rs to the plasma membrane may be cell-type
dependent [29], only type III IP3Rs are plasma membrane-
localized in osteoclasts. Several studies have reported an
IP3R-induced release of Ca2+ from the nucleus and the local-
ization of IP3Rs to the nuclear membrane [9, 25]. In the
present study, we were unable to determine whether the
IP3Rs were localized to the nuclear membrane.
The osteoclast cytoskeleton is characterized by the
presence of specific adhesion structures called podosomes
Fig. 1. Expression of IP3R (I, type I; II, type II; and III, type III)
mRNA in rat osteoclasts. Cath K, cathepsin K mRNA; M, molec-
ular marker. Arrow=150 bp, arrowhead=300 bp. (c) Cathepsin K
expression with and without reverse transcription; RT(+) and
RT(−), respectively. M, molecular marker. (d) Phase contrast
image of bone marrow cells cultured for 1 week. Bar=30 µm.Morikawa et al. 10
that contain actin microfilaments surrounded by vinculin
and talin [24]. Double-staining with anti-IP3Rs and TRITC-
phalloidin revealed the colocalization of type III IP3Rs and
podosomes. IP3R subtypes have been reported as being relat-
ed to focal contact cytoskeletal proteins [27]. The colocal-
ization of type III IP3Rs and podosomes raises the possibility
that type III IP3Rs may be involved in Ca2+ signaling at focal
contacts. Focal contacts, which consist of assemblies of
cytoskeletal proteins, play an important role in stabilizing
cell adhesion, structure, and mobility [5, 19, 20]. Numer-
ous studies have reported that inositol phospholipids and
enzymes in the inositol signaling pathway, such as phos-
phatidylinositol kinase, phosphatidylinositol 4-phosphate
kinase, and phospholipase C, have important roles in the
formation of actin stress fibers [4, 10, 12, 23]. Cellular ad-
hesion and migration are regulated by an increase in intra-
Fig. 2. Immunofluorescence microscopy of cultured osteoclasts incubated with anti-IP3R (types I, II, and III) antibodies and DiOC6. (a, e, i)
Staining of the ER in cultured osteoclasts by DiOC6. Immunofluorescence images showing the colocalization of IP3R type I (b), type II (f), and
type III (j) with the ER. IP3R type III was localized at the ER and the periphery of the cells (j, arrows). Nomarski images for each osteoclast (c,
g, k) and merged images for DiOC6 and each IP3R (d, h, l). Staining for IP3R type I (m), type II (n), and type III (o) alone. (p) Negative control.
Cells were viewed under confocal laser microscopy (60×, oil). Bars=10 µm (d, h, l) and 2 µm (p). Optical path setting: DiOC6; KrAr Laser:
10.0, Iris: 2.0, Gain: 60.0, Offset: 0.0, each IP3R; KrAr Laser: 30.0, Iris: 2.0–3.0, Gain: 60.0, Offset: 0.0, Nomarski; KrAr Laser: 100.0, Gain:
100.0, Offset: 0.0.IP3 Receptors in Osteoclasts 11
Fig. 3. Fluorescence images showing the podosomes and type III IP3Rs in cultured osteoclasts. (b) TRITC-phalloidin staining indicates the
punctate distribution of the podosomes at the periphery of the cells. (a) The distribution of IP3R type III was similar to that of the podosomes. (c,
d) Close-up view of the area enclosed by a yellow square in (a, b). Image of IP3R type III staining (e), image of podosome staining (f) and
merged image of IP3R type III/podosome staining (g) at the X/Z section on the yellow line in (a). Image of IP3R type III staining (h), image of
podosome staining (i), a Nomarski image (j) and merged image of IP3R type III/podosome staining (k). (l) Staining for IP3R type III alone. Yel-
low rectangle shows a close-up view of the area in the small yellow rectangle in (l). As in (a), dot-like signals were observed at the periphery of
the cells. (m) Negative control. Cells were viewed under confocal laser microscopy (60×, oil). Bars=5 µm (b), 1 µm (d, g, l; inset), and 10 µm
(k–m). Optical path setting: TRITC-phalloidin and IP3R type III; KrAr Laser: 30.0, Iris: 2.0–3.0, Gain: 60.0, Offset: 0.0, Nomarski; KrAr Laser:
100.0, Gain: 100.0, Offset: 0.0.Morikawa et al. 12
cellular Ca2+ [4]. Moreover, peripheral actin accumulation
is produced by potential-dependent Ca2+ channels [8]. The
podosomes in osteoclasts contain numerous actin microfila-
ments; thus, type III IP3Rs may induce the accumulation of
actin filaments by increasing the concentration of Ca2+.
Taken together, these findings suggest that type III IP3Rs
take part in cellular adhesion in osteoclasts. Additional
studies using IP3R antagonists are needed to clarify the asso-
ciation between type III IP3Rs and the formation of cellular
adhesions in osteoclasts.
The formation of a complete actin ring in osteoclasts
cultured on a dentin surface reveals not only the strong
attachments between osteoclasts but also the high bone-
resorptive activity of osteoclasts [14, 17]. We detected a
relatively clear actin ring at the periphery of the osteo-
clasts on the dentin slice compared to those on the cover
glasses, and type III IP3R immunoreactivity was observed
in the region of the actin ring in the dentin-cultured osteo-
clasts. The colocalization of type III IP3Rs and actin sug-
gests that IP3R type III may be related to the bone-resorptive
activity of osteoclasts.
In conclusion, the IP3Rs in osteoclasts are predominant-
ly ER-localized; however, type III IP3Rs are also associated
with attachment structures known as podosomes. Although
our data strongly suggest a relationship between IP3Rs and
cellular attachment in osteoclasts, further study is needed to
elucidate the function of IP3Rs in osteoclasts.
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